Drugs & Targets BMS, Enterome collaborate on microbiome-derived biomarkers December 02, 2016Vol.42 No.44
Drugs & Targets Darzalex Approved for Multiple Myeloma; Iclusig Approved for CML December 02, 2016Vol.42 No.44
Drugs & Targets FDA Approves New Indications for Darzalex, Keytruda, Opdivo November 29, 2016Vol.39 No.10
Drugs & Targets Amgen, Allergan submit application for biosimilar bevacizumab November 18, 2016Vol.42 No.43
Drugs & Targets Hopkins and BMS announce five-year collaboration to study resistance to checkpoint blockers and develop combination immunotherapies. November 11, 2016Vol.42 No.42
Drugs & Targets Amgen and Janssen Biotech to evaluate combination of Amgen’s Kyprolis and Janssen’s Darzalex in multiple clinical studies in multiple myeloma November 11, 2016Vol.42 No.42
